Mendelson Jordan L, Jacobs Anna, Vega Diego Alvarez, Brenseke William, Glasser Chana, Fine Ronnie G, Friedman Steven C, Horowitz Mark, Gitlin Jordan S
Division of Pediatric Urology, Department of Urology, New York University Langone Hospital-Long Island, Mineola, NY, USA.
Department of Surgery, New York University Langone Hospital-Long Island, Mineola, NY, USA.
J Pediatr Urol. 2024 Dec 24. doi: 10.1016/j.jpurol.2024.12.014.
Parental refusal of intramuscular (IM) vitamin K in newborns poses challenges, particularly for pediatric urologists assessing the safety of neonatal circumcision. Vitamin K deficiency bleeding (VKDB) is a known risk, with lack of prophylaxis increasing bleeding complications. This study evaluates the safety of neonatal circumcision without IM vitamin K, reviews guidelines, and explores alternative prophylaxis options.
To assess if neonatal circumcision can be safely performed on infants lacking IM vitamin K and to identify both optimal timing and alternative prophylactic approaches.
We conducted a literature review using PubMed and Google Scholar to gather data on neonatal circumcision and VKDB in the context of IM vitamin K refusal. Additionally, we searched for relevant guidelines from the American Urological Association (AUA), American Academy of Pediatrics (AAP), and other organizations. Our study included analysis of ten recent cases of neonatal circumcision without IM vitamin K, focusing on safety outcomes and timing.
IM vitamin K is the most effective prophylaxis against VKDB, significantly reducing bleeding risk up to sixfold in neonatal circumcision. Oral vitamin K, sometimes used as an alternative in Europe, shows variable effectiveness and lacks standardization in the U.S. Newborn prothrombin (PT) levels fluctuate significantly in the first week: PT levels are high at birth, drop within 24 h, reach a nadir at 24-72 h, then rebound. Circumcisions performed at 14 days on ten patients without IM vitamin K showed no bleeding complications, suggesting that timing circumcisions after PT stabilization may be safer.
IM vitamin K prophylaxis should remain standard care. In cases of refusal, alternative prophylaxis and timing circumcision after the PT nadir may improve safety. This study underscores the need for updated guidelines from professional organizations, including the AUA, to address the growing trend of IM vitamin K refusal and its implications for neonatal circumcision.
新生儿家长拒绝给其注射维生素K带来了诸多挑战,尤其是对于评估新生儿包皮环切术安全性的儿科泌尿科医生而言。维生素K缺乏性出血(VKDB)是一种已知风险,缺乏预防措施会增加出血并发症。本研究评估了不进行维生素K注射的新生儿包皮环切术的安全性,回顾了相关指南,并探讨了替代预防方案。
评估在缺乏维生素K注射的婴儿身上进行新生儿包皮环切术是否安全,并确定最佳时机和替代预防方法。
我们使用PubMed和谷歌学术进行文献综述,以收集在家长拒绝维生素K注射情况下有关新生儿包皮环切术和VKDB的数据。此外,我们还搜索了美国泌尿外科学会(AUA)、美国儿科学会(AAP)及其他组织的相关指南。我们的研究包括对近期十例未注射维生素K的新生儿包皮环切术病例的分析,重点关注安全性结果和时机。
维生素K注射是预防VKDB最有效的方法,在新生儿包皮环切术中可将出血风险显著降低多达六倍。口服维生素K在欧洲有时用作替代方法,但其有效性参差不齐,在美国也缺乏标准化。新生儿凝血酶原(PT)水平在出生后第一周波动很大:出生时PT水平较高,24小时内下降,在24至72小时达到最低点,然后反弹。对十名未注射维生素K的患者在14天时进行包皮环切术未出现出血并发症,这表明在PT稳定后进行包皮环切术可能更安全。
维生素K注射预防应仍是标准治疗方法。在家长拒绝的情况下,替代预防措施以及在PT最低点后进行包皮环切术可能会提高安全性。本研究强调了包括AUA在内的专业组织需要更新指南,以应对维生素K注射拒绝情况日益增多的趋势及其对新生儿包皮环切术的影响。